Efficacy and Safety of Anlotinib Plus EGFR-TKIs in Slowly or Locally Progressing NSCLC after Adjuvant Therapy with EGFR-TKIs

被引：0
|
作者：
Ye, J. [1 ]
Liu, J. [1 ]
Yang, Y. [1 ]
Lv, W. [1 ]
Xu, W. [2 ]
Xia, P. [1 ]
Wang, L. [1 ]
Zhu, L. [1 ]
Hu, J. [1 ,3 ]
机构：
[1] Zhejiang Univ, Affiliated Hosp 1, Hangzhou, Peoples R China
[2] Sanmen Peoples Hosp, Taizhou, Peoples R China
[3] Key Lab Clin Evaluat Technol Med Device Zhejiang, Hangzhou, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期
关键词：
Anlotinib; NSCLC; EGFR-TKIs;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP.07E.04
引用
收藏
页码：S554 / S554
页数：1
相关论文
共 50 条
  • [21] Revolutionizing NSCLC Treatment: Immunotherapy Strategies for EGFR-TKIs Resistance
    Tian, Jin
    Shi, Zhiqi
    Zhao, Lili
    Liu, Peng
    Sun, Xiaojun
    Long, Lin
    Zang, Jianhua
    Xiao, Jun
    CLINICAL RESPIRATORY JOURNAL, 2024, 18 (12):
  • [22] Intratumoral heterogeneity and EGFR-TKIs resistance
    Zhou, Caicun
    Cai, Weijing
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (02) : S15 - S15
  • [23] THE RESISTANCE TO EGFR-TKIS IN LUNG CANCER
    Yamada, T.
    Yano, S.
    ANNALS OF ONCOLOGY, 2012, 23 : 77 - 77
  • [24] Irreversible EGFR-TKIs: dreaming perfection
    Landi, Lorenza
    Cappuzzo, Federico
    TRANSLATIONAL LUNG CANCER RESEARCH, 2013, 2 (01) : 40 - 49
  • [25] The differential efficacy of docetaxel according to NSCLC histology and therapeutic effect of EGFR-TKIs
    Miura, S.
    Murakami, H.
    Naito, T.
    Tsuya, A.
    Nakamura, Y.
    Kaira, K.
    Takahashi, T.
    Endo, M.
    Onozawa, Y.
    Yamamoto, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [26] EGFR-TKIs or EGFR-TKIs combination treatments for untreated advanced EGFR-mutated NSCLC: a network meta-analysis (vol 24, 1390, 2024)
    Liu, Ao
    Wang, Xiaoming
    Wang, Lian
    Zhuang, Han
    Xiong, Liubo
    Gan, Xiao
    Wang, Qian
    Tao, Guanyu
    BMC CANCER, 2025, 25 (01)
  • [27] EGFR-TKIs - induced cardiotoxicity in NSCLC: incidence, evaluation, and monitoring
    Wang, Yunlong
    Qiu, Qinggui
    Deng, Xuan
    Wan, Mengchao
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [28] Advanced NSCLC Patients at the Extremes of Age in the Era of EGFR-TKIs
    Chen, Yu-Mu
    Lai, Chien-Hao
    Chang, Huang-Chih
    Chao, Tung-Ying
    Tseng, Chia-Cheng
    Fang, Wen-Feng
    Chung, Yu-Hsiu
    Wang, Yi-Hsi
    Su, Mao-Chang
    Huang, Kuo-Tung
    Wang, Chin-Chou
    Lin, Meng-Chih
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1445 - S1445
  • [29] Efficacy and Safety of Radiotherapy Plus EGFR-TKIs in NSCLC Patients with Brain Metastases: A Meta-Analysis of Published Data
    Wang, Xueyan
    Xu, Ye
    Tang, Weiqing
    Liu, Lingxiang
    TRANSLATIONAL ONCOLOGY, 2018, 11 (05): : 1119 - 1127
  • [30] EGFR-TKIs in adjuvant treatment of lung cancer: to give or not to give?
    Milovancev, Aleksandar
    Stojsic, Vladimir
    Zaric, Bojan
    Kovacevic, Tomi
    Sarcev, Tatjana
    Perin, Branislav
    Zarogoulidis, Konstantinos
    Tsirgogianni, Katerina
    Freitag, Lutz
    Darwiche, Kaid
    Tsavlis, Drosos
    Zissimopoulos, Athanasios
    Stratakos, Grigoris
    Zarogoulidis, Paul
    ONCOTARGETS AND THERAPY, 2015, 8 : 2915 - 2921
12345